A new peer reviewed paper has evidenced the effectiveness of Micro-Fragmented Adipose Tissue (MFAT) in treating osteoarthritis of the knee.
It shows that, out of 110 knees assessed for patient-centred outcomes of pain, functionality and quality of life, 81% of people responded positively and had an improvement in their arthritis and a significant decrease in their experience of pain.
Conducted over 12 months on patients at The Regenerative Clinic in London, the results show that more than 4 in 5 patients have responded well to their Lipogems treatment for arthritic knees.
Simon Checkley, CEO, The Regenerative Clinic, says: “The potential is clear and we must now fully document the positive effects of using Mesenchymal stem cells, derived from fat, as an alternative for many orthopaedic conditions.
“This is a minimally invasive procedure that can be an alternative to major surgery. It can even aid post-surgery recovery. There are no major incisions or cuts. It can help in injury or with a long-term condition that limits daily activity and as a minimally invasive alternative to pain relief.
“There is much more work to do in proving the value of this treatment and we now need to validate findings with a long-term randomised controlled trial.”
Interview: Walking the walk in health tech
Rethinking automation in pharmaceutical processing
How VR is helping to beat eating disorders
Anaesthesia device deal signed
Agetech accelerator winner
COVID-19: the catalyst for a more resilient supply chain
How an NHS Trust is using tech to prepare for a “worst case scenario”
Let’s seize the moment and tackle digital inequality
AI could reduce misdetection of breast cancer by up to 20%
Investment interview: Kathy Gibson, the Innovation Seed Fund
Sign up to our newsletter